U.S. Markets closed
  • S&P 500

    3,666.72
    -2.29 (-0.06%)
     
  • Dow 30

    29,969.52
    +85.73 (+0.29%)
     
  • Nasdaq

    12,377.18
    +27.82 (+0.23%)
     
  • Russell 2000

    1,848.70
    +10.67 (+0.58%)
     
  • Crude Oil

    45.70
    +0.06 (+0.13%)
     
  • Gold

    1,844.40
    +3.30 (+0.18%)
     
  • Silver

    24.18
    +0.04 (+0.18%)
     
  • EUR/USD

    1.2152
    +0.0037 (+0.3038%)
     
  • 10-Yr Bond

    0.9200
    -0.0280 (-2.95%)
     
  • Vix

    21.28
    +0.11 (+0.52%)
     
  • GBP/USD

    1.3449
    +0.0073 (+0.5487%)
     
  • USD/JPY

    103.8470
    -0.5770 (-0.5526%)
     
  • BTC-USD

    19,452.16
    +503.26 (+2.66%)
     
  • CMC Crypto 200

    382.19
    +7.79 (+2.08%)
     
  • FTSE 100

    6,490.27
    +26.88 (+0.42%)
     
  • Nikkei 225

    26,809.37
    +8.39 (+0.03%)
     

Iovance Biotherapeutics: 3Q Earnings Snapshot

·1 min read

SAN CARLOS, Calif. (AP) _ Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $58.6 million in its third quarter.

The San Carlos, California-based company said it had a loss of 40 cents per share.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.

Iovance Biotherapeutics shares have risen 46% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $40.42, a climb of 85% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA